Fewer Pills, Lower Bills: Antihypertensive and Cost Outcomes of Adrenalectomy in Primary Aldosteronism
Patients with PA who undergo adrenalectomy demonstrate a significant reduction in antihypertensive medications compared with medically managed patients. While there is significant upfront cost to surgical intervention, reduced long-term prescription costs are realized.
Authors
- Lily Owei (ORCID: https://orcid.org/0000-0002-5112-3831)
- Heather Wachtel (ORCID: https://orcid.org/0000-0003-3786-3638)
- Jesse E. Passman (ORCID: https://orcid.org/0000-0002-6599-0397)
- Jasmine Hwang (ORCID: https://orcid.org/0000-0002-8546-2276)
- Jordana B. Cohen (ORCID: https://orcid.org/0000-0003-4649-079X)
- Lauren R. Kelz
- Taryn Barrett
- Colleen Brensinger
Institutions
- Hospital of the University of Pennsylvania (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Annals of Surgical Oncology
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1245/s10434-026-19347-0
- Primary Topic
- Hormonal Regulation and Hypertension
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Cancer Institute